Radko Komers, MD, PhD
Travere Therapeutics, Inc.
4
0
3
N/A
0
5
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (4)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Matthias Kretzler, MD
University of Michigan
Shared therapeutic areas:
William A Gahl, M.D.
National Human Genome Research Institute (NHGRI)
Shared therapeutic areas:
Yasar Caliskan, MD
Division of Nephrology, Department of Internal Medicine, Istanbul Faculty of Medicine
Shared therapeutic areas:
Sydney CW Tang, MD, PhD
The University of Hong Kong
Shared therapeutic areas:
Safak Mirioglu, MD
Department of Internal Medicine, Istanbul Faculty of Medicine
Shared therapeutic areas:
Halil Yazici, MD
Department of Internal Medicine, Istanbul Faculty of Medicine
Shared therapeutic areas:
Anping Xu, MD
Department of Nephrology, 2nd Affiliated Hospital of Sun Yet-Sen University,Guangzhou
Shared therapeutic areas:
Jinli Zhang, MD
Department of nephrology, People's Hospital of Yunnan Province
Shared therapeutic areas:
Zhangsuo liu, MD
Department of Nephrology, 1st Affiliated hospital of Zhengzhou University, Henan
Shared therapeutic areas:
J. Bruce German, PhD
University of California, Davis
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (4)
Showing 4 of 4 trials
A Study to Investigate Safety and Effect of Sparsentan in Combination With SGLT2 Inhibition in Participants With IgAN
Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
A Study of the Effect and Safety of Sparsentan in the Treatment of Patients With IgA Nephropathy
Study of Sparsentan in Patients With Primary Focal Segmental Glomerulosclerosis (FSGS)
All 4 trials loaded